Early Discontinuation of Ethambutol in Pulmonary Tuberculosis Treatment Based on Results of the GenoType MTBDRplus Assay: a Prospective, Multicenter, Noninferiority Randomized Trial in South Korea

No studies have investigated whether the discontinuation of ethambutol (EMB) based on susceptibility to isoniazid and rifampin, as determined by the GenoType MTBDRplus assay, would be appropriate. We aimed to determine the feasibility of discontinuing EMB before the end of the intensive phase of tre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Jo, Kyung-Wook, Kim, Mihye, Kim, Ye-Jee, Lee, Hyun-Kyung, Kim, Hyun Kuk, Jeon, Doosoo, Lyu, Jiwon, Park, Hye Kyeong, Mok, Jeongha, Kim, Ju Sang, Heo, Eun Young, Choi, Sang Bong, Yim, Jae-Joon, Shim, Tae Sun
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2019
Fag:
Clinical Therapeutics
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6879208/
https://ncbi.nlm.nih.gov/pubmed/31527020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00980-19
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker